About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

No Longer AvailableNCT06063746

Compassionate Use of Vidutolimod

Provide Compassionate Use of Vidutolimob

Lead sponsor: Regeneron Pharmaceuticals•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Regeneron Pharmaceuticals

Compassionate use is only available to patients who transitioned from a previous vidutolimod (CMP-001) study.

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•\-

Exclusion Criteria

•\-

Related studies

RECRUITINGPhase 1

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

NCT05039801 · Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, and more

Active Not RecruitingPhase 2

Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial

NCT04284774 · Malignant Solid Neoplasm, Recurrent Adrenal Gland Pheochromocytoma, and more

TERMINATEDPhase 2

Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma

NCT04093323 · HLA-A2 Positive Cells Present, Refractory Melanoma

COMPLETEDPhase 2

Study of CP-675,206 in Refractory Melanoma

NCT00254579 · Refractory Melanoma

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 8, 2026Terms

Trial snapshot

StatusNO_LONGER_AVAILABLE

Phase—

Enrollment—

Start date—

Last updatedJan 8, 2026

Condition

Refractory Melanoma

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 8, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions